| Literature DB >> 35162799 |
Amal A Alghamdi1, Nora O Alafif2, Ahmed S BaHammam3,4, May Almuammar2, Najd S Alharbi2, Nouf A Alhefdhi2, Sara Al-Musharaf2, Kholoud S Al Ghamdi5, Ghada F AlYousif1, Norah F Al Muhanna6.
Abstract
PURPOSE: During the coronavirus disease 2019 (COVID-19) pandemic quarantine, university students were under various types of stressors, including the exams period, which might have affected their quality and quantity of sleep, and consequently, their quality of life. This study aimed to investigate the pattern and predictors of nightmares among university students and coinvestigate the presence of other types of sleep disturbances, mental disorders, and quarantine-related stressors.Entities:
Keywords: anxiety; coronavirus; depression; nightmares; quarantine; university
Mesh:
Year: 2022 PMID: 35162799 PMCID: PMC8835620 DOI: 10.3390/ijerph19031776
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Directed acyclic graph used in building the regression model adjustment and testing the study hypothesis. The squares represent the study’s variables, and the arrows represent the direction of the relationship between the study’s variables.
The distribution of sociodemographic features of the study participants in relation to gender.
| Male | Female | Total | X2 | Df |
| |||
|---|---|---|---|---|---|---|---|---|
| % | % | |||||||
| Family income | 0.857 * | |||||||
| Low | 0 | 0.00 | 2 | 84.7 | 2 | |||
| Middle low | 52 | 39.39 | 93 | 39.40 | 145 | |||
| Middle | 3 | 2.27 | 7 | 2.96 | 10 | |||
| Middle high | 60 | 45.45 | 110 | 46.61 | 170 | |||
| High | 17 | 12.87 | 24 | 10.16 | 41 | |||
| Marital status | 0.028 * | |||||||
| Single | 124 | 93.93 | 232 | 98.30 | 356 | |||
| Married | 8 | 6.06 | 44 | 18.64 | 12 | |||
| School | 50.90 | 3 | <0.001 | |||||
| Science and architect | 60 | 45.45 | 177 | 75 | 237 | |||
| Medicine and Health | 5 | 3.78 | 13 | 5.50 | 18 | |||
| Humanity and art | 57 | 43.18 | 26 | 11.01 | 83 | |||
| Administration and management | 10 | 7.57 | 20 | 8.47 | 30 | |||
| Father education | 10.17 | 4 | 0.038 | |||||
| Primary education | 8 | 6.06 | 10 | 4.23 | 18 | |||
| Secondary education | 20 | 15.15 | 16 | 6.77 | 36 | |||
| High school | 31 | 23.48 | 72 | 30.50 | 103 | |||
| University | 45 | 34.09 | 98 | 41.52 | 143 | |||
| Postgraduate | 28 | 21.21 | 40 | 16.94 | 68 | |||
| Mother education | 0.58 | 4 | 0.965 | |||||
| Primary education | 14 | 10.60 | 22 | 9.32 | 36 | |||
| Secondary education | 15 | 11.36 | 27 | 11.44 | 42 | |||
| High school | 39 | 29.54 | 78 | 33.05 | 117 | |||
| University | 56 | 42.42 | 96 | 40.67 | 152 | |||
| Postgraduate | 8 | 6.81 | 13 | 5.50 | 21 | |||
| Academic year | 35.93 | 5 | <0.001 | |||||
| 1st | 30 | 22.72 | 25 | 45.45 | 55 | |||
| 2nd | 32 | 56.14 | 25 | 43.86 | 57 | |||
| 3rd | 26 | 37.68 | 43 | 62.32 | 69 | |||
| 4th | 17 | 16.50 | 86 | 83.50 | 103 | |||
| 5th | 16 | 32.65 | 33 | 67.35 | 49 | |||
| 6th | 11 | 31.43 | 24 | 68.57 | 35 | |||
| Academic failure | 20.22 | 1 | <0.001 | |||||
| No | 92 | 30.55 | 209 | 69.44 | 301 | |||
| Yes | 40 | 59.70 | 27 | 40.30 | 67 | |||
| GPA | 46.16 | 3 | <0.001 | |||||
| D | 7 | 77.78 | 2 | 22.22 | 9 | |||
| C | 35 | 76.09 | 11 | 23.91 | 46 | |||
| B | 49 | 29.34 | 118 | 70.66 | 167 | |||
| A | 41 | 28.08 | 105 | 71.92 | 146 | |||
| Chronic disease | 0.679 | 1 | 0.4101 | |||||
| No | 122 | 36.53 | 212 | 63.47 | 334 | |||
| Yes | 10 | 29.41 | 24 | 70.59 | 34 | |||
| Smoking | 52.36 | 1 | <0.001 | |||||
| No | 88 | 28.21 | 224 | 71.79 | 312 | |||
| Yes | 44 | 78.57 | 12 | 21.43 | 56 | |||
| Regular physical exercise | 0.142 | 1 | 0.707 | |||||
| No | 92 | 36.51 | 160 | 63.49 | 252 | |||
| Yes | 40 | 34.48 | 76 | 65.52 | 116 | |||
*p-value comes from Fisher exact test.
Distribution of nightmare indicators amongst study participants concerning gender (n = 368).
| Male | Female | Total | X2 | Df |
| |||
|---|---|---|---|---|---|---|---|---|
| % | % | |||||||
| Presence of nightmares | 6.55 | 1 | 0.010 | |||||
| No | 101 | 40.24 | 150 | 59.76 | 251 | |||
| Yes | 31 | 26.50 | 86 | 73.50 | 117 | |||
| New onset of nightmare or increased frequency in relation to COVID-19 | 7.29 | 1 | 0.007 | |||||
| No | 122 | 38.61 | 194 | 61.39 | 316 | |||
| Yes | 10 | 19.23 | 42 | 80.77 | 52 | |||
| Change in the frequency of nightmares before and after COVID-19 | 14.35 | 2 | 0.001 | |||||
| Did not change | 102 | 42.68 | 137 | 57.32 | 239 | |||
| Increased or new-onset | 10 | 19.23 | 42 | 80.77 | 52 | |||
| Decrease | 20 | 25.97 | 57 | 74.03 | 77 | |||
| Frequency of nightmares during COVID-19 | 19.23 | 3 | <0.001 | |||||
| No nightmare | 91 | 45.73 | 108 | 54.27 | 199 | |||
| Daily | 5 | 35.71 | 9 | 64.29 | 14 | |||
| >=3 times per week | 8 | 21.62 | 29 | 78.38 | 37 | |||
| <3 times per week | 28 | 23.73 | 90 | 76.27 | 118 | |||
| Nightmare theme during COVID-19 | <0.001 * | |||||||
| No nightmares | 91 | 45.73 | 108 | 54.27 | 199 | |||
| Related to the pandemic | 7 | 5.30 | 15 | 6.36 | 22 | |||
| ◦ Catching COVID-19 disease | 2 | 25.00 | 6 | 75.00 | 8 | |||
| ◦ Loss of loved ones | 4 | 57.14 | 3 | 42.86 | 7 | |||
| ◦ Death of themselves | 1 | 20.00 | 4 | 80.00 | 5 | |||
| ◦ Diseases in general | 0 | 0.00 | 2 | 2 | 2 | |||
| ◦ Others not related to COVID-19 | 34 | 23.13 | 113 | 76.87 | 147 | |||
| ◦ Falling or driving very fast | 2 | 28.57 | 5 | 71.43 | 7 | |||
| ◦ Fighting | 0 | 0.00 | 2 | 100 | 2 | |||
| ◦ Lost or kidnapped | 0 | 0.00 | 4 | 100 | 4 | |||
| ◦ Academic life and exams | 0 | 0.00 | 5 | 100 | 5 | |||
| ◦ Natural disaster | 2 | 66.67 | 1 | 33.33 | 3 | |||
| ◦ Future or past events | 0 | 0.00 | 3 | 100 | 3 | |||
| ◦ Supranatural creatures or unexplained emotions | 18 | 26.47 | 50 | 73.53 | 68 | |||
| ◦ Cannot remember | 1 | 11.11 | 8 | 88.89 | 9 | |||
| Bothered by nightmares | <0.001 * | |||||||
| No nightmare s | 91 | 45.73 | 108 | 54.27 | 199 | |||
| Bother me a lot | 4 | 18.18 | 18 | 81.82 | 22 | |||
| Bother me a little | 8 | 22.22 | 28 | 77.78 | 36 | |||
| Does not bother me | 19 | 25.00 | 57 | 75.00 | 76 | |||
| Does not bother me at all | 10 | 28.57 | 25 | 71.43 | 35 | |||
| Back to sleep after a nightmare | 20.95 | 3 | <0.001 | |||||
| No nightmares | 91 | 45.73 | 108 | 54.27 | 199 | |||
| Difficulty going back to sleep | 5 | 13.16 | 33 | 86.84 | 38 | |||
| Stay awake some time before going back to sleep | 22 | 27.85 | 57 | 72.15 | 79 | |||
| Sleep immediately | 14 | 26.92 | 38 | 73.08 | 52 | |||
| Overcome nightmares | <0.001 * | |||||||
| No nightmares | 91 | 45.73 | 108 | 54.27 | 199 | |||
| Talk to family members | 2 | 5.00 | 38 | 95.00 | 40 | |||
| Talk to friends | 11 | 26.83 | 30 | 73.17 | 41 | |||
| Consult a physician | 25 | 32.47 | 52 | 67.53 | 77 | |||
| Internet search | 0 | 0.00 | 1 | 100 | 1 | |||
| No action | 3 | 30.00 | 7 | 70.00 | 10 | |||
* p-value resulted from Fisher exact test, (x2) = chi-square test, (DF) = degree of freedom, (p) = p-value.
Distribution of sleep disturbance components measured using GSDS concerning gender and presence of nightmares (n = 368).
| Male ( | Female ( | Total ( | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No Nightmares | With Nightmares | No Nightmares | With Nightmares | No Nightmares | With Nightmares | |||||||
| % | % | % | % | % | % | |||||||
| Difficulty falling asleep | X2(1) = 1.18, | X2(1) = 21.95, | X2(1) = 21.85, | |||||||||
| <=times/week | 49 | 73.13 | 18 | 26.87 | 63 | 63.64 | 36 | 36.36 | 112 | 67.47 | 54 | 32.53 |
| >3 times/week | 42 | 64.62 | 23 | 35.38 | 45 | 32.85 | 92 | 67.15 | 87 | 43.07 | 115 | 56.93 |
| Waking up during sleep | X2(1) = 0.57, | X2(1) = 6.589, | X2(1) = 9.17, | |||||||||
| <=times/week | 53 | 71.62 | 21 | 28.38 | 55 | 55.56 | 44 | 44.44 | 108 | 62.43 | 65 | 37.57 |
| >3 times/week | 38 | 65.52 | 20 | 34.48 | 53 | 38.69 | 84 | 61.31 | 91 | 46.67 | 104 | 53.33 |
| Waking up too early from sleep | X2(1) = 7.64, | X2(1) = 2.60, | X2(1) = 12.55, | |||||||||
| <=times/week | 61 | 78.21 | 17 | 21.79 | 50 | 52.08 | 46 | 47.92 | 111 | 63.79 | 63 | 36.21 |
| >3 times/week | 30 | 55.56 | 24 | 44.44 | 58 | 41.43 | 82 | 58.57 | 88 | 45.36 | 106 | 54.64 |
| Poor Quality of sleep | X2(1) = 0.03, | X2(1) = 0.69, 0.406 | X2(1) = 0.66, | |||||||||
| <=times/week | 34 | 68.00 | 16 | 32.00 | 39 | 42.39 | 53 | 57.61 | 73 | 51.41 | 69 | 48.59 |
| >3 times/week | 57 | 69.51 | 25 | 30.49 | 69 | 47.92 | 75 | 52.08 | 126 | 55.75 | 100 | 44.25 |
| Abnormal quantity of sleep | X2(1) = 2.55, | X2(1) = 1.37, | X2(1) = 3.46, | |||||||||
| <=times/week | 40 | 43.96 | 12 | 29.27 | 46 | 42.59 | 45 | 35.16 | 86 | 60.14 | 57 | 39.86 |
| >3 times/week | 51 | 56.04 | 29 | 70.73 | 62 | 57.41 | 83 | 64.84 | 113 | 50.22 | 112 | 49.78 |
| Use of substances to help induce sleep | ||||||||||||
| <=times/week | 89 | 97.80 | 38 | 92.68 | 108 | 100.00 | 127 | 99.22 | 197 | 54.42 | 165 | 45.58 |
| >3 times/week | 2 | 2.20 | 3 | 7.32 | 0 | 0.00 | 1 | 100 | 2 | 33.33 | 4 | 66.67 |
| Day-time sleepiness | X2(1) = 5.7115, | X2(1) = 5.64, | X2(1) = 14.51, | |||||||||
| <=times/week | 66 | 72.53 | 21 | 51.22 | 64 | 59.26 | 56 | 43.75 | 130 | 62.80 | 77 | 37.20 |
| >3 times/week (161) | 25 | 27.47 | 20 | 48.78 | 44 | 40.74 | 72 | 56.25 | 69 | 42.86 | 92 | 57.14 |
* p-value resulted from Fisher exact test, (x2) = chi-square test, (p) = p-value.
Results of several adjusted and unadujsted logistic regression models that estimated the risk of having anxiety and depression in relation to several nightmare indicators.
| Number of Patients with Anxiety | Anxiety | Number of Patients with Depression | Depression | ||||
|---|---|---|---|---|---|---|---|
| Unadjusted OR (CI) | Adjusted * OR (CI) | Unadjusted OR (CI) | Adjusted * | ||||
| Presence of nightmares | No | 44 | Ref. | 71 | |||
| Yes | 56 | 56 | |||||
| New onset of nightmares related to COVID-19 | No | 85 | Ref. | 110 | Ref. | ||
| Yes | 18 | 1.10 (0.58, 2.11) | 1.05 (0.54, 2.07) | 17 | 0.91 (0.49, 1.70) | 0.94 (0.49, 1.81) | |
| Change in the frequency of nightmares before and after COVID-19 | Did not change | 29 | Ref. | 54 | |||
| Increased | 15 | 1.57 (0.79, 3.09) | 1.47 (0.73, 2.97) | 17 | 1.20(0.63, 2.28) | ||
| Decreased | 36 | 41 | 1.58 (0.95, 2.62) | ||||
| Frequency of nightmares during COVID-19 | No nightmare | 29 | Ref. | 54 | |||
| >=3 times per week | 28 | 28 | |||||
| <3 times per week | 43 | 45 | 1.66 (1.02, 2.69) | 1.58 (0.95, 2.62) | |||
| Nightmare theme during COVID-19 | No nightmare | 29 | Ref. | 54 | |||
| COVID-19 related | 12 | 10 | |||||
| Not related to COVID-19 | 59 | 63 | 2.28 (0.90, 5.79) | ||||
| Bothered by nightmares | No nightmare | 29 | Ref. | 54 | |||
| Does not bother me | 34 | 35 | 1.24 (0.74, 2.05) | 1.23 (0.73, 2.10) | |||
| Bothers me | 37 | 38 | |||||
| Back to sleep after a nightmare | No nightmare | 29 | Ref. | 54 | |||
| Difficulty going back to sleep | 28 | 29 | |||||
| Stay awake some time before going back to sleep | 25 | 26 | 1.39 (0.78, 2.49) | ||||
| Sleep immediately | 18 | 18 | 1.42 (0.74, 2.73) | 1.32 (0.67, 2.59) | |||
| Overcome nightmares | No nightmare | 29 | Ref. | 54 | |||
| Talk to family members | 16 | 17 | 1.98 (0.99, 3.99) | 1.8 (0.86, 1.92) | |||
| Talk to friends | 23 | 23 | |||||
| Consult a physician | 30 | 29 | 1.59 (0.91, 2.77) | 1.54 (0.87, 2.75) | |||
| No action | 2 | 1.47 (0.29, 7.25) | 1.47 (0.29, 7.47) | 4 | 1.79 (0.49, 6.59) | 1.71 (0.45, 6.57) | |
* Adjusted for academic year, gender, socioeconomic status, chronic diseases, smoking, exercise. Bold fonts indicate significant results (p-value < 0.0).
Results of logistic regression models that estimated the risk of having anxiety and depression in relation to sleep disturbance components.
| Number of Patients with Anxiety | Anxiety | Number of Patients with Depression | Depression | ||||
|---|---|---|---|---|---|---|---|
| Unadjusted OR (CI) | Adjusted * | Unadjusted OR (CI) | Adjusted * OR (CI) | ||||
| Difficulty falling asleep | <=times/week | 25 | Ref. | 46 | |||
| >3 times/week | 75 |
|
| 81 |
|
| |
| Waking up during sleep | <=times/week | 30 | Ref. | 41 | |||
| >3 times/week | 70 |
|
| 86 |
|
| |
| Waking up too early from sleep | <=times/week | 32 | Ref. | 51 | |||
| >3 times/week | 68 |
|
| 76 | 1.55 (0.047, 1.00) | 1.47 (0.93, 2.31) | |
| Poor Quality of sleep | <=times/week | 45 | Ref. | 53 | |||
| >3 times/week | 55 | 0.69 (0.43, 1.11) | 0.64 (0.39, 1.05) | 74 | 0.82 (0.53, 1.27) | 0.79 (0.50, 1.26) | |
| Abnormal quantity of sleep | <=times/week | 25 | Ref. | 31 | |||
| >3 times/week | 75 |
|
| 96 |
|
| |
| Use of substances to help induce sleep | <=times/week | 99 | Ref. | 125 | |||
| >3 times/week | 1 | 0.53 (0.061, 4.60) | 0.48 (0.05, 4.44) | 2 | 0.95 (0.17, 5.25) | 0.88 (0.15, 5.19) | |
| Daytime sleepiness | <=times/week | 22 | Ref. | 44 | |||
| >3 times/week | 78 |
|
| 83 |
|
| |
* Adjusted for academic year, gender, socioeconomic status, chronic diseases, smoking, exercise. Bold fonts indicate significant results (p-value < 0.05).